CONSTELLATION PHARMACEUTICALS CEO Jigar Raythatha's 2020 pay jumps 154% to $5.9M
CONSTELLATION PHARMACEUTICALS reports 2020 executive compensation
By ExecPay News
Published: April 23, 2021
CONSTELLATION PHARMACEUTICALS reported fiscal year 2020 executive compensation information on April 23, 2021.
In 2020, five executives at CONSTELLATION PHARMACEUTICALS received on average a compensation package of $2.9M, a 91% increase compared to previous year.
Average pay of disclosed executives at CONSTELLATION PHARMACEUTICALS
Jigar Raythatha, Chief Executive Officer, received $5.9M in total, which increased by 154% compared to 2019. 86% of Raythatha's compensation, or $5.1M, was in option awards. Raythatha also received $244K in non-equity incentive plan, $544K in salary, as well as $12K in other compensation.
Jeffrey Humphrey, Chief Medical Officer, received a compensation package of $3.2M. 85% of the compensation package, or $2.7M, was in option awards.
Emma Reeve, Chief Financial Officer, earned $2.1M in 2020, a 89% increase compared to previous year.
Patrick Trojer, Chief Scientific Officer, received $1.9M in 2020.
Karen Valentine, Chief Legal Officer, earned $1.6M in 2020.
Related executives
Jigar Raythatha
CONSTELLATION PHARMACEUTICALS
Chief Executive Officer
Emma Reeve
CONSTELLATION PHARMACEUTICALS
Chief Financial Officer
Patrick Trojer
CONSTELLATION PHARMACEUTICALS
Chief Scientific Officer
Karen Valentine
CONSTELLATION PHARMACEUTICALS
Chief Legal Officer
Jeffrey Humphrey
CONSTELLATION PHARMACEUTICALS
Chief Medical Officer
You may also like
Source: SEC filing on April 23, 2021.